These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of inhaled dry powder mannitol on mucus and its clearance. Daviskas E; Rubin BK Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816 [TBL] [Abstract][Full Text] [Related]
7. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Daviskas E; Anderson SD; Eberl S; Chan HK; Bautovich G Am J Respir Crit Care Med; 1999 Jun; 159(6):1843-8. PubMed ID: 10351929 [TBL] [Abstract][Full Text] [Related]
9. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B; Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664 [TBL] [Abstract][Full Text] [Related]
10. Inhaled mannitol for the treatment of cystic fibrosis. Hurt K; Bilton D Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575 [TBL] [Abstract][Full Text] [Related]
11. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults. Gjoerup J; Hilberg O; Bendstrup E Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014 [TBL] [Abstract][Full Text] [Related]
12. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. Daviskas E; Robinson M; Anderson SD; Bye PT J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422 [TBL] [Abstract][Full Text] [Related]
13. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis. Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992 [TBL] [Abstract][Full Text] [Related]
14. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. Bilton D; Daviskas E; Anderson SD; Kolbe J; King G; Stirling RG; Thompson BR; Milne D; Charlton B; Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction. Daviskas E; Anderson SD; Eberl S; Young IH Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419 [TBL] [Abstract][Full Text] [Related]
17. Dornase alfa for cystic fibrosis. Yang C; Chilvers M; Montgomery M; Nolan SJ Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279 [TBL] [Abstract][Full Text] [Related]
18. Hyperosmolar agents and clearance of mucus in the diseased airway. Daviskas E; Anderson SD J Aerosol Med; 2006; 19(1):100-9. PubMed ID: 16551221 [TBL] [Abstract][Full Text] [Related]
19. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Daviskas E; Anderson SD; Eberl S; Chan HK; Young IH Chest; 2001 Feb; 119(2):414-21. PubMed ID: 11171717 [TBL] [Abstract][Full Text] [Related]
20. Timing of hypertonic saline inhalation for cystic fibrosis. Elkins M; Dentice R Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008816. PubMed ID: 28146603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]